Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems

G

Giulio Frontino

Status

Not yet enrolling

Conditions

Diabetes Mellitus, Type 1

Treatments

Device: Tandem Control IQ

Study type

Observational

Funder types

Other

Identifiers

NCT06305377
DESPED-T1 study

Details and patient eligibility

About

The rational of this study is to assess if AHCL systems are able to achieve a better metabolic control (better glucometric data) after 2 weeks, 1 months. 6 months and 1 year after the start, in adolescents in not good glycaemic control.

Enrollment

20 estimated patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All children met the American Diabetes Association (ADA) criteria for T1D diagnosis with a current HbA1c of ≥8.5%.
  • Age range 12-17 yrs old

Exclusion criteria

  • Patients with a diagnose of genetic form of diabetes will be excluded.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems